{
    "2020-08-24": [
        [
            {
                "time": "",
                "original_text": "连锁药店屡创新高，背后有怎样的逻辑？",
                "features": {
                    "keywords": [
                        "连锁药店",
                        "新高",
                        "逻辑"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "零售",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大局已变，国药上药包揽96%国采配送，另两家只分到零头",
                "features": {
                    "keywords": [
                        "国药",
                        "上药",
                        "国采",
                        "配送",
                        "市场格局"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "只有10%玩家能存活下来的游戏，创新药的风险显然被市场低估！",
                "features": {
                    "keywords": [
                        "创新药",
                        "风险",
                        "市场低估"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海市委市人大常委会市政府市政协领导常态化走访企业",
                "features": {
                    "keywords": [
                        "上海",
                        "政府",
                        "走访企业",
                        "政策支持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天津信托股权变更获银保监会批准 上实集团成控股股东 控制人变化",
                "features": {
                    "keywords": [
                        "天津信托",
                        "股权变更",
                        "银保监会",
                        "上实集团",
                        "控股股东"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "信托"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物第三批带量采购点评：集采常态化 本轮降幅略超预期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "带量采购",
                        "集采",
                        "降幅",
                        "超预期"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "手握产能和成本优势 罗欣药业集采拿下两大品种",
                "features": {
                    "keywords": [
                        "罗欣药业",
                        "产能",
                        "成本优势",
                        "集采",
                        "品种"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}